Ieq Capital LLC Sells 416 Shares of DocuSign, Inc. (NASDAQ:DOCU)

Ieq Capital LLC reduced its stake in DocuSign, Inc. (NASDAQ:DOCU) by 2.6% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 15,828 shares of the company’s stock after selling 416 shares during the period. Ieq Capital LLC’s holdings in DocuSign were worth $1,424,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the stock. State Street Corp raised its holdings in DocuSign by 2.3% in the third quarter. State Street Corp now owns 5,372,939 shares of the company’s stock worth $333,604,000 after purchasing an additional 120,743 shares during the period. Geode Capital Management LLC increased its position in shares of DocuSign by 1.6% in the 3rd quarter. Geode Capital Management LLC now owns 3,483,184 shares of the company’s stock valued at $215,789,000 after buying an additional 53,554 shares in the last quarter. Thrivent Financial for Lutherans raised its stake in DocuSign by 5.2% during the 3rd quarter. Thrivent Financial for Lutherans now owns 2,277,312 shares of the company’s stock worth $141,398,000 after buying an additional 112,919 shares during the period. FMR LLC lifted its holdings in DocuSign by 16.8% during the third quarter. FMR LLC now owns 2,192,885 shares of the company’s stock worth $136,156,000 after acquiring an additional 315,073 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in DocuSign by 14.4% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,659,367 shares of the company’s stock valued at $103,030,000 after acquiring an additional 208,813 shares during the period. 77.64% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other DocuSign news, Director Daniel D. Springer sold 581,588 shares of the business’s stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $97.04, for a total transaction of $56,437,299.52. Following the transaction, the director now owns 906,430 shares of the company’s stock, valued at $87,959,967.20. The trade was a 39.08 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Allan C. Thygesen sold 7,763 shares of the company’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $80.54, for a total value of $625,232.02. Following the completion of the sale, the chief executive officer now owns 100,062 shares in the company, valued at $8,058,993.48. This represents a 7.20 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 693,773 shares of company stock valued at $66,727,926. 1.66% of the stock is owned by insiders.

Analyst Ratings Changes

DOCU has been the topic of a number of research analyst reports. Hsbc Global Res raised DocuSign to a “moderate sell” rating in a research report on Friday, December 6th. JMP Securities restated a “market outperform” rating and set a $124.00 target price on shares of DocuSign in a report on Tuesday, January 7th. UBS Group upped their price target on shares of DocuSign from $60.00 to $100.00 and gave the company a “neutral” rating in a report on Friday, December 6th. JPMorgan Chase & Co. raised their price objective on shares of DocuSign from $50.00 to $70.00 and gave the stock an “underweight” rating in a report on Tuesday, December 3rd. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of DocuSign in a research note on Tuesday, February 4th. Three investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $92.45.

DocuSign Stock Performance

Shares of NASDAQ DOCU opened at $83.69 on Tuesday. The stock has a 50 day moving average price of $91.45 and a 200 day moving average price of $77.09. The stock has a market capitalization of $16.91 billion, a PE ratio of 17.26, a price-to-earnings-growth ratio of 6.94 and a beta of 0.89. DocuSign, Inc. has a 52 week low of $48.70 and a 52 week high of $107.86.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.